GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

Two words come to mind for Elizabeth Banks after her showdown with shingles: "Not fun." ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B round.

Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...

GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...

As adults age, the greater their chances of getting shingles. That is why health care experts recommend all adults 50 and ...

Recently, AIM announced a comprehensive deployment to integrate the DeepSeek large model, particularly in vaccine development ...

Even if you received childhood vaccinations it’s important to consult a doctor to determine whether you need a booster shot ...

Patients who have a date of birth from September 2, 1943 and August 31, 1953 will have previously been called for vaccination ...

The shingles vaccine isn’t just for preventing the rash—it may also help protect the heart and brain. According to research led by James Mbinta, the vaccine lowers the risk of heart attacks and ...